| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1358891 | Bioorganic & Medicinal Chemistry Letters | 2015 | 5 Pages |
Abstract
To develop the first radiotracer targeting GPR91, a cell membrane-bound receptor that modulates the cellular response to hyperglycemia and hypoxia, we designed and prepared a small series of compounds based on a published series of 1,8-naphthyridines with high affinity to GPR91. Our approach provides a mechanism to incorporate radioactive atoms (99mTc and 18F) into the GPR91 pharmacophore as the final synthetic step. Pharmacological assays confirmed lead compounds for 99mTc and 18F GPR91 radiotracers within the series.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jeffrey Klenc, Malgorzata Lipowska, Andrew T. Taylor,